๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

21 recruiting trials

for Cerebral Vein Thrombosis

DOAC in Chinese Patients With Atrial Fibrillation NCT05378035n/a1 site๐Ÿ“ Hong Kong Chinese University of Hong Kong ยท Tests: Blood Tests VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization NCT06873321Phase 41 site๐Ÿ“ Pernambuco Science Valley Research Institute ยท Tests: rivaroxaban 2.5 mg bid + aspirin 100 mg, clopidogrel 75 mg od for 3 months followed by aspirin 100 mg od for endovasculโ€ฆ Anticoagulation Combined With Tocilizumab for Interleukin-6 Receptor Inhibition in Acute Cerebral Venous Thrombosis NCT07801638NA1 site๐Ÿ“ Beijing Capital Medical University ยท Tests: Tocilizumab, Standard Treatment MENA Regional Endovascular Intervention for Venous Cerebral Venous Sinus Thrombosis NCT07548346NA14 sites๐Ÿ“ Alexandria๐Ÿ“ Cairo๐Ÿ“ Cairo Middle East North Africa Stroke and Interventional Neurotheโ€ฆ ยท Tests: Endovascular Thrombectomy, Anticoagulation Therapy Treatment Outcomes of Direct Oral Anticoagulants in Cerebral Venous Thrombosis in Vietnam NCT07083609n/a1 site๐Ÿ“ Hanoi Hieu Trung Dinh ยท Tests: Dabigatran, Rivaroxaban Safety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese Patients NCT06947707n/a1 site๐Ÿ“ Beijing Xuanwu Hospital, Beijing Timing of Venous Thromboembolism Prophylaxis in Patients With Hypertensive Intracerebral Hemorrhage NCT06753786NA1 site๐Ÿ“ Moscow Pirogov Russian National Research Medical University ยท Tests: Venous thromboembolism prophylaxis with unfractionated heparin or low molecular weight heparin starting within the firsโ€ฆ Dabigatran Versus Rivaroxaban in Cerebral Venous Thrombosis NCT06551402Phase 31 site๐Ÿ“ Kafr ash Shaykh Kafrelsheikh University ยท Tests: Dabigatran Etexilate 150mg, Rivaroxaban 20 MG Oral Tablet Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis NCT07521332Phase 41 site๐Ÿ“ Hyderฤbฤd Asian Institute Of Medical Sciences ยท Tests: Apixaban, Carvedilol, Placebo Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation NCT05679024Phase 334 sites๐Ÿ“ Helsinki๐Ÿ“ Tampere๐Ÿ“ Turku Region Stockholm ยท Tests: Apixaban 2.5 milligram Oral Tablet Mobilisation After Endovascular Stroke Treatment NCT07860333n/a2 sites๐Ÿ“ Tampere๐Ÿ“ Stockholm Karolinska Institutet ยท Tests: Mobilisation The Norwegian Cerebral Venous Thrombosis Study NCT05021198n/a1 site๐Ÿ“ Lรธrenskog University Hospital, Akershus PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST) NCT03559114Phase 312 sites๐Ÿ“ Calgary๐Ÿ“ Edmonton๐Ÿ“ Edmonton Sunnybrook Health Sciences Centre ยท Tests: Dalteparin, Saline Heat Shock Protein 47 in Thrombosis NCT06731673n/a2 sites๐Ÿ“ Aarhus๐Ÿ“ Berlin University of Aarhus The Erlanger Stroke Registry (ESPro) is the Only Ongoing Prospective Population-based Stroke Registry in Germany, Started in 1994. ESPro Includes All Hospitalized and Non-hospitalized Patients With Stroke in the Community of Erlangen (120.000 Inhabitants), With a Long-life Follow-up. NCT07771335n/a3 sites๐Ÿ“ Erlangen๐Ÿ“ Erlangen๐Ÿ“ Erlangen University of Erlangen-Nรผrnberg Medical School Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis NCT04660747n/a1 site๐Ÿ“ Amsterdam Academisch Medisch Centrum - Universiteit van Amsterdam (AMโ€ฆ ยท Tests: Oral anticoagulant Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable NCT07430956Phase 344 sites๐Ÿ“ Dothan๐Ÿ“ Glendale๐Ÿ“ Little Rock Regeneron Pharmaceuticals ยท Tests: REGN7508, REGN9933, Placebo Danang Cerebral Venous Thrombosis Registry NCT07890675n/a1 site๐Ÿ“ Da Nang Da Nang Hospital ยท Tests: Standard Anticoagulant Therapy GEKO Venous Thromboembolism Prevention Study NCT05476913NA18 sites๐Ÿ“ Bury St Edmunds๐Ÿ“ Bath๐Ÿ“ Birmingham Firstkind Ltd ยท Tests: gekoโ„ข device Cerebral Venous Thrombosis Cohort Study in China Mainland NCT03919305n/a1 site๐Ÿ“ Beijing Capital Medical University Randomized Trial of Anticoagulation Plus Batroxobin for Acute Cerebral Venous Thrombosis NCT07352358Phase 41 site๐Ÿ“ Beijing Xuanwu Hospital, Beijing ยท Tests: batroxobin, Anticoagulation Agents
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy